Vitamin D2026-05

Treatment of Hypovitaminosis D Is Associated with Improvement in Anemia of Inflammation in Patients with Decompensated Cirrhosis.

Diaz-Ruiz Raquel, Poca Maria, Roman Eva, Cuyàs Berta et al. — Medical sciences (Basel, Switzerland)

Summary

This study explored whether treating low vitamin D levels could help patients with severe liver disease who also suffer from anemia and inflammation. Researchers found that supplementing vitamin D, alongside other nutrients, led to improvements in their anemia and a reduction in inflammatory markers over three months. This suggests vitamin D might play a role in managing these complications in such patients.

AI-generated summary — read the original

Key points

Patients with severe liver disease (decompensated cirrhosis) often have low vitamin D levels.
Supplementing vitamin D improved anemia in these patients over a three-month period.
The improvement in anemia was linked to a significant decrease in inflammatory markers.
Vitamin D may help manage anemia in this context by reducing systemic inflammation.

What the study looked at

This study investigated whether correcting low vitamin D levels could improve anemia and reduce inflammation in patients suffering from severe liver disease (decompensated cirrhosis). Researchers followed 39 patients with decompensated cirrhosis who had low vitamin D. Over three months, these patients received vitamin D supplements, and their blood was tested for vitamin D levels, hemoglobin (a measure of anemia), and markers of inflammation. The findings showed that after three months, patients' vitamin D levels significantly increased. Importantly, their hemoglobin levels also improved, meaning less anemia, and a key inflammatory marker (Interleukin-6) decreased. The study suggests that treating vitamin D deficiency may help alleviate anemia in these patients by modulating systemic inflammation.

Dietary takeaway

While this research focused on a specific group with severe liver disease, it adds to our understanding of vitamin D's broader role in the body, particularly its potential influence on inflammation and blood health. For general readers, ensuring adequate vitamin D intake through fortified foods like milk and cereals, fatty fish such as salmon, or safe sun exposure remains important for overall well-being. However, it's crucial to remember that this is just one study, and more research is needed to confirm these findings and their applicability to the wider population.

Abstract

: Anemia of inflammation (AI) is a prevalent condition linked to systemic inflammation in several chronic diseases, including chronic liver diseases. Hypovitaminosis D is frequently identified in patients with chronic diseases, and its pathogenic role in anemia is currently under investigation. The aim of this study was to prospectively investigate changes in hemoglobin concentration and inflammatory markers in vitamin D-deficient/-insufficient patients with decompensated cirrhosis after initiating vitamin D supplementation, in addition to the supplementation of other micronutrients if needed. : Patients with cirrhosis discharged from decompensation were assessed at baseline and 3 months after vitamin D supplementation. Laboratory parameters of red cell series, nutrition, and micronutrients were assessed in both visits, together with markers of systemic inflammation. : Thirty-nine patients were included in the study, of whom 33 completed the 3-month evaluation and were analyzed [age: 62.7 ± 10.7 years; gender: n = 29 (87.9%) males; Charlson index: 5.9 ± 1.6; Model for End-Stage Liver Disease (MELD): 12.4 ± 4.5; baseline hemoglobin (Hb): 11.7 ± 1.8 g/dL (anemia n = 24 (72.7%)); mean 25-hydroxyvitamin D (25OHD) plasma level: 15.5 ± 8.6 µg/L]. A significant increase in plasma 25OHD (40.1 ± 17.8, < 0.001) and in Hb (12.4 ± 2.0, = 0.01) was observed at 3 months with a decrease in the prevalence of anemia (n = 17, = 0.015) and of Interleukin 6 in plasma levels [IL-6, 10.7 (5.8-23.3) vs. 6.5 (4.1-11.8), = 0.016]. A greater rise in hemoglobin was correlated with higher plasma IL-6 concentration at baseline. Milder anemia and indexes of hypoferremia at baseline, along with optimal renal function and plasma levels of 25OHD at 3 months, were linked to resolution of anemia. : Treating vitamin D deficiency together with other micronutrient deficits is associated with inflammation amelioration and improvement in anemia in patients with cirrhosis following discharge from acute decompensation. This paper supports the potential role of vitamin D in the management of anemia in patients with decompensated cirrhosis by modulating systemic inflammation.

View on PubMed →DOI: 10.3390/medsci14020267